CVRX
CVRx, Inc.
CVRx, Inc. (CVRX) has 14 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jun 3, 2026.
Insiders have net sold $127K over the trailing 6 months.
- Industry:Medical - Devices
- CEO:Kevin Hykes
- Employees:223
- HQ:Minneapolis, MN, US
- IPO:2021-06-30
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$127K
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$137.3M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Adamson Philip B.First filing | Chief Medical Officer | Sale | 1,262 | $10K | Mar 16 | SEC ↗ |
VERRASTRO PAULFirst filing | CHIEF MKTG & STRAT OFFICER | Sale | 1,284 | $10K | Mar 3 | SEC ↗ |
Hykes KevinFirst filing | PRES & CEO | Sale | 7,763 | $61K | Mar 3 | SEC ↗ |
OASHEIM JAREDFirst filing | CHIEF FINANCIAL OFFICER | Sale | 1,744 | $14K | Mar 3 | SEC ↗ |
John Robert AllenFirst filing | Chief Revenue Officer | Sale | 3,964 | $31K | Mar 3 | SEC ↗ |
Related companies
CVRx, Inc. is in the Healthcare sector.